Montes Archimedes Acquisition Corp. (MAAC)
| Market Cap | 507.75M |
| Revenue (ttm) | n/a |
| Net Income (ttm) | n/a |
| Shares Out | 41.07M |
| EPS (ttm) | n/a |
| PE Ratio | n/a |
| Forward PE | n/a |
| Dividend | n/a |
| Dividend Yield | n/a |
| Trading Day | May 7 |
| Last Price | $9.91 |
| Previous Close | $9.91 |
| Change ($) | 0.00 |
| Change (%) | 0.00% |
| Day's Open | 9.93 |
| Day's Range | 9.89 - 9.93 |
| Day's Volume | 160,070 |
| 52-Week Range | 9.61 - 10.87 |
A drug discovery company with ownership stakes in several public and private biopharmaceutical companies is going public with a SPAC deal announced Monday morning. The SPAC Deal: Roviant Sciences announ...
MENLO PARK, Calif., Nov. 25, 2020 /PRNewswire/ -- Montes Archimedes Acquisition Corp. (Nasdaq: MAACU) (the "Company") announced that, commencing November 27, 2020, holders of the units sold in the Compa...
U.S. IPO Weekly Recap: Healthcare Dominates A 7 IPO Week
MENLO PARK, Calif., Oct. 6, 2020 /PRNewswire/ -- Montes Archimedes Acquisition Corp (the "Company" or "Montes Archimedes"), a special purpose acquisition company formed for the purpose of entering into ...
About MAAC
Montes Archimedes Acquisition Corp. focuses to effect a merger, capital stock exchange, asset acquisition, stock purchase, reorganization, or other business combination with one or more businesses. The company was incorporated in 2020 and is based in Menlo Park, California.
| Industry Shell Companies | IPO Date Oct 7, 2020 |
| Stock Exchange NASDAQ | Ticker Symbol MAAC |